Red cell distribution width/platelet ratio estimates the 3-year risk of decompensation in Metabolic Dysfunction-Associated Steatotic Liver Disease-induced cirrhosis

Table 9 Type of first decompensation event of non-acute and acute decompensating patients

Type of first decompensation event	NAD-decompensating patients (n = 29)	AD-decompensating patients (n = 14)
(A) Slow/ grade 1 ascites formation [n (%)]	14 (48.3)	/
(B) Mild (grade 1/2) hepatic encephalopathy [n (%)]	6 (20.7)	/
(C) Jaundice in non-cholestatic cirrhosis [n (%)]	9 (31)	/
A + B/A + C	2/5
(D) Grade 2/3 ascites within less than 2 wk [n (%)]	/	5 (35.7)
(E) Severe acutea hepatic encephalopathy [n (%)]	/	4 (28.5)
(F) Acute gastrointestinal bleeding [n (%)]	/	2 (14.3)
(G) Acute bacterial infection	/	3 (21.5)

^aIn patients with previous normal consciousness.

AD: Acute decompensation; NAD: Non-acute decompensation.